News | December 01, 2008

Bracco Studies Support Products’ Clinical Safety and Efficacy

December 1, 2008 – At RSNA 2008, Bracco highlighted studies of its products that were the subject of multiple studies this past year, which reportedly demonstrated the company’s dedication to the manufacture of products that provide clinical safety and efficacy, including the following:

- The MR-ENHANCE study – a controlled multicenter double-blind randomized intraindividual crossover study design – published in the American Journal of Neuroradiology, suggests that the higher relaxivity of Bracco’s MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, may be linked to greater signal intensity, better contrast enhancement and better lesion conspicuity in MRI of the brain than gadodiamide.

- The PREDICT study (Patients with REnal impairment and DIabetes undergoing Computed Tomography), a prospective, randomized, double-blind comparison published in the American Journal of Roentgenology, reinforces the results of earlier published studies, IMPACT and CARE , in that it also failed to find a statistically significant difference in contrast-induced nephropathy (CIN) rates between iopamidol 370 mgl/mL (Isovue-370) and iodixanol 320 mgl/mL when administered in patients who are at high risk for a decline in renal function following the administration of intravascular contrast media.

- The ACRIN CT Colonography study published in The New England Journal of Medicine showcases the results from the largest multicenter trial on the efficacy of CT Colonography (CTC), also known as VC. With the use of Bracco’s PROTOCO2L, an automated carbon dioxide insufflation system for VC, and Tagitol V (barium sulfate suspension 40% w/v, 30% w/w) Bracco’s fecal tagging agent, researchers were able to demonstrate comparable accuracy for VC and standard colonoscopy. PROTOCO2L and Tagitol V were established as ACRIN clinical standards for use in VC.

- The Diagnostic Performance of PET Myocardial Perfusion Imaging study, a meta-analysis – published in Academic Radiology, provides a combined evaluation of numerous published studies in cardiac positron emission tomography (PET) MPI, confirming its excellent sensitivity and specificity in the diagnosis of coronary artery disease.

Related Content

Study Finds No Evidence that Gadolinium Causes Neurologic Harm

MR images through, A, C, E, basal ganglia and, B, D, F, posterior fossa at level of dentate nucleus. Images are shown for, A, B, control group patient 4, and the, C, D, first and, E, F, last examinations performed in contrast group patient 13. Regions of interest used in quantification of signal intensity are shown as dashed lines for globus pallidus (green), thalamus (blue), dentate nucleus (yellow), and pons (red).

News | Contrast Media | January 11, 2018
January 11, 2018 — There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive dec
Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Imaging | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
Videos | Magnetic Resonance Imaging (MRI) | December 19, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
The FDA issued new warnings on MRI gadolinium contrast agents. (GBCAs)

The FDA issued new warnings on MRI gadolinium contrast agents. 

Feature | Magnetic Resonance Imaging (MRI) | December 19, 2017
The U.S.
Brainlab Contrast Clearance Analysis Software Receives FDA 510(k) Clearance
Technology | Contrast Media | December 12, 2017
Brainlab announced U.S. Food and Drug Administration (FDA) clearance of its Contrast Clearance Analysis methodology,...
Sectra Offers Gadolinium Tracking Functionality in DoseTrack Software
Technology | Contrast Media | December 11, 2017
December 11, 2017 — Sectra recently announced the global introduction of gadolinium tracking in its dose monitoring s
Videos | Magnetic Resonance Imaging (MRI) | December 07, 2017
Max Wintermark, M.D., professor of radiology and chief of neuroradiology, Stanford Hospital and Clinics, discussed MR
Guerbet to Participate in French Interventional Radiology Conference
News | Contrast Media | October 10, 2017
Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will...
Trends in contrast media used in magnetic resonance imaging and computed tomography

Image courtesy of Bayer

Feature | Contrast Media | October 04, 2017 | By Dave Fornell
Over the past decade, several clinical studies have shown gadolinium-based magnetic resonance imaging (MRI) contrast...
Overlay Init